相关实验视频

Updated: May 6, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

扩大对化学抗原受体T细胞的治疗策略

Edward J Goetzl¹

¹Department of Medicine, University of California San Francisco.

The American journal of medicine

|March 29, 2025

概括

化学抗原受体 (CAR) 免疫细胞显示出治疗各种疾病的前景,包括癌症和自身免疫性疾病. 目前正在进行的研究重点是提高CAR T细胞治疗的有效性和安全性,以改善患者的治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

化学抗原受体 (CAR) 免疫细胞被设计为在患病细胞上向特定抗原.
针对CD19或B细胞成熟抗原的CAR T细胞疗法被FDA批准用于B细胞恶性瘤.
改进了CAR结构,以提高持久性,减少非目标效应,提高有效性.

研究的目的:

审查目前CAR免疫细胞疗法的现状.
讨论CAR结构设计的进步及其对治疗结果的影响.
突出CAR免疫细胞疗法的挑战和未来方向.

主要方法:

关于CAR免疫细胞疗法的现有文献的综述.
对FDA批准的CAR T细胞系统及其目标进行分析.
讨论减轻CAR免疫细胞相关毒性的策略.

主要成果:

卡尔T细胞疗法在血液性恶性瘤中取得了成功.
改进CAR构造的目的是提高持久性并最大限度地减少副作用.
像细胞因子释放综合征和神经毒性等急性副作用是可以管理的,但需要注意.

结论:

CAR免疫细胞疗法是一个快速发展的领域,具有显著的治疗潜力.
未来CAR T细胞工程的进步,包括体内方法和mRNA编辑,有望提高安全性和有效性.
解决诸如同源环境中的移植对宿主反应等挑战对于更广泛的应用至关重要.

关键词:

自身免疫性疾病是一种自身免疫性疾病.在B细胞恶性瘤中.多发性骨髓瘤是一种多发性骨髓瘤.移植移植移植移植

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.